- Home
- FHTX vs TRX Comparison
FHTX vs TRX Comparison
Compare FHTX & TRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHTX
- TRX
- Stock Information
- Founded
- FHTX 2015
- TRX 1990
- Country
- FHTX United States
- TRX Canada
- Employees
- FHTX N/A
- TRX N/A
- Industry
- FHTX Medicinal Chemicals and Botanical Products
- TRX
- Sector
- FHTX Health Care
- TRX
- Exchange
- FHTX Nasdaq
- TRX Nasdaq
- Market Cap
- FHTX 246.6M
- TRX 228.9M
- IPO Year
- FHTX 2020
- TRX N/A
- Fundamental
- Price
- FHTX $5.21
- TRX $0.64
- Analyst Decision
- FHTX Strong Buy
- TRX Strong Buy
- Analyst Count
- FHTX 6
- TRX 2
- Target Price
- FHTX $11.83
- TRX $1.15
- AVG Volume (30 Days)
- FHTX 270.9K
- TRX 1.2M
- Earning Date
- FHTX 11-05-2025
- TRX 11-28-2025
- Dividend Yield
- FHTX N/A
- TRX N/A
- EPS Growth
- FHTX N/A
- TRX N/A
- EPS
- FHTX N/A
- TRX N/A
- Revenue
- FHTX $24,518,000.00
- TRX $47,731,000.00
- Revenue This Year
- FHTX $42.43
- TRX $33.23
- Revenue Next Year
- FHTX $14.77
- TRX $34.65
- P/E Ratio
- FHTX N/A
- TRX $604.29
- Revenue Growth
- FHTX N/A
- TRX 29.98
- 52 Week Low
- FHTX $2.95
- TRX $0.27
- 52 Week High
- FHTX $8.45
- TRX $0.85
- Technical
- Relative Strength Index (RSI)
- FHTX 63.51
- TRX 51.36
- Support Level
- FHTX $4.63
- TRX $0.61
- Resistance Level
- FHTX $5.69
- TRX $0.66
- Average True Range (ATR)
- FHTX 0.40
- TRX 0.04
- MACD
- FHTX 0.12
- TRX -0.00
- Stochastic Oscillator
- FHTX 74.95
- TRX 67.98
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About TRX TRX Gold Corporation
TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. It is focused on the Buckreef Gold Project which comprises five prospects, namely Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba.